MabCure, Inc. (MBCI) Comparison with companies in other sectors?

MabCure, Inc. has a share price of 70.30M. You can analyze MabCure, Inc. (MBCI) competitors across different market sectors through stock heatmaps.

What are MBCI's NET and operating margins?

MabCure, Inc. (MBCI) operating margin is around -1.42, and net profit margin is approximately -24.90 as of the latest reports.

In what way does MBCI's earnings per share (EPS) trend reflect its financial momentum?

MabCure, Inc. (MBCI) EPS is -0.01 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for MabCure, Inc. is -0.01, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for MabCure, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for MabCure, Inc. like P/E which is 0.00, P/B which is 0.00, and PEG which is 0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

MabCure, Inc.

MBCI•PNK

Energy

Solar

$0.00

$-0.00(-0.00%)

Fundamental Analysis of MabCure, Inc. (MBCI)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.01

P/E Ratio

-0.01

ROE

-1.27%

Net Margin

-24.90%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$7.03K

Shares OutstandingTotal number of shares issued

$70.30M

Book Value/ShareNet worth per share

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.01

Net MarginNet income as percentage of revenue

-2490.30%

Operating MarginOperating income as percentage of revenue

-141.95%

ROEReturn on shareholders' equity

-127.05%

ROAReturn on total assets

-258.80%

ROCEReturn on capital employed

-18.31%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

FCF YieldFree cash flow as percentage of market cap

-891.21%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for MBCIFinancial Ratios Analysis details for MBCI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for MBCISector Benchmarking details for MBCI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for MabCure, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of MabCure, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account MabCure, Inc.'s unique business strengths and challenges.

Key Financial Metrics for MabCure, Inc.

For MabCure, Inc., essential financial indicators include EPS -0.01, PE -0.01, and ROE -1.27. These key ratios reveal insights into MabCure, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare MabCure, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of MabCure, Inc.

Metrics like Net Margin -2490.30% and ROA -258.80% shed light on how well MabCure, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether MabCure, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of MabCure, Inc.

Using ratios such as P/B Ratio - and PEG Ratio -, investors can assess whether MabCure, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with MabCure, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for MabCure, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.07 and Cash Flow -, provide a snapshot of MabCure, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like MabCure, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for MabCure, Inc.

Investing in MabCure, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at MabCure, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;